A Comparative Study on the Effect of Different Management Options on Body Mass Index in Overweight Polycystic Ovarian Syndrome Patients at a Tertiary Care Hospital

Abstract

Introduction: According to the data from the World Health Organization, polycystic ovarian syndrome (PCOS) may affect as many as 116 million women worldwide (3.4%). The main objective of the study was to determine the effectiveness of treatment on the body mass index (BMI) of overweight PCOS patients. Materials and Methods: This prospective, observational study was conducted from December 2022 to February 2023 and 252 PCOS patients were included in the study. Results: A detailed analysis of the risk factors in the study population concluded that a family history of the PCOS, lack of exercise, regular consumption of fast food, broiler chicken, high sugar, soft drinks, and packed foods had contributed to the lifestyle syndrome, where each showed a P = 0.0001. Conclusion: The comparative analysis of the treatment effectiveness in terms of BMI among three treatment strategies—(1) medication, (2) lifestyle, and (3) medication along with lifestyle established the conclusion that the treatment with lifestyle alone and lifestyle along with medication together showed similar extend in weight reduction in overweight PCOS patients after performing post hoc statistical analysis. However, a greater proportion of people who experienced weight reduction falls under lifestyle + exercise.

Keywords

• body mass index
• lifestyle
• medication
• polycystic ovarian syndrome
• post hoc analysis
• risk factors
• weight gain
• weight reduction